Artiva Biotherapeutics (ARTV) Stock: Buy, Sell, or Hold?
ARTV - Artiva Biotherapeutics, Inc. Common Stock
$6.83
0.04 (0.59%)
▲
5d:
-2.29%
30d:
-39.61%
90d:
-27.65%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When ARTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ARTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ARTV is currently trading at $6.83, which is considered oversold relative to its 30-day fair value range of $7.91 to $11.39.
Technical Outlook: Technically, ARTV is in a uptrend. The price is currently testing key support at $6.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $35.80 (+424.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARTV is in a uptrend. The price is currently testing key support at $6.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $35.80 (+424.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.91 -
$11.39
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 424.2% below Wall St target ($35.80)
- NEUTRAL: Bottoming setup forming (45/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$7.91 -
$11.39
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.74
Resistance Level
$8.64
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.62
Wall Street Target
$35.80
(+424.2%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: October 04, 2026 11:47 AM ET
Data refreshes hourly during market hours. Next update: 12:47 PM
Data refreshes hourly during market hours. Next update: 12:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARTV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$571 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 56 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
29 analysts |
$371 | 49 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
20 analysts |
$307 | 66 BUY |
|
STOK
Stoke Therapeutics Inc |
STRONG BUY
14 analysts |
$46 | 71 BUY |
